ClinicalTrials.gov
ClinicalTrials.gov Menu

Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00001158
Recruitment Status : Completed
First Posted : December 10, 2002
Last Update Posted : March 5, 2008
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)

Brief Summary:
The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be utilized.

Condition or disease
Immunologic Deficiency Syndromes Neoplasms

Detailed Description:
The goal of the protocol is to define the normal humoral and cellular immune responses to antigens in volunteers and to define abnormalities of these immune responses in patients with immunodeficiency diseases or cancer. In vitro assays and in vivo skin tests and immunization with antigens will be utilized.

Study Type : Observational
Official Title: Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
Study Start Date : April 1977
Study Completion Date : March 2000




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria
Patients will be studied if a disorder of the immune system is suspected.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00001158


Locations
United States, Maryland
National Cancer Institute (NCI)
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
National Cancer Institute (NCI)

Publications:
ClinicalTrials.gov Identifier: NCT00001158     History of Changes
Other Study ID Numbers: 770066
77-C-0066
First Posted: December 10, 2002    Key Record Dates
Last Update Posted: March 5, 2008
Last Verified: April 1999

Keywords provided by National Institutes of Health Clinical Center (CC):
Cellular Immunity
Humoral Immunity
Immunodeficiency Disease

Additional relevant MeSH terms:
Immunologic Deficiency Syndromes
Immune System Diseases